FDA Grants Moderna's COVID-19 Vaccine Full Approval
- 2 years ago
FDA Grants Moderna's, COVID-19 Vaccine , Full Approval.
On January 31, Moderna announced that its
COVID-19 vaccine has been granted full approval
by United States health regulators. .
On January 31, Moderna announced that its
COVID-19 vaccine has been granted full approval
by United States health regulators. .
The Associated Press reports that since its
emergency authorization over a year ago, the vaccine
has already been given to tens of millions of Americans. .
The Associated Press reports that since its
emergency authorization over a year ago, the vaccine
has already been given to tens of millions of Americans. .
In August of 2021, the FDA granted
full approval to Pfizer's vaccine.
The Associated Press reports that over
211 million Americans are fully vaccinated -
about 63% of the population. .
The Associated Press reports that over
211 million Americans are fully vaccinated -
about 63% of the population. .
Approximately 86 million people have
received at least one dose of a booster. .
According to the AP, vaccinations peaked at over
3 million doses were distributed per day last spring.
Now, daily doses average less than 750,000. .
The AP reports that the vaccine's initial
emergency approval was based on a study
that tracked 44,000 people for two months.
Moderna then continued that study
to complete longer six-month-long studies
normally required for full approval. .
The FDA reportedly monitored for serious side effects that have proven to be extremely rare. .
The FDA reportedly monitored for serious side effects that have proven to be extremely rare. .
Last fall, the FDA delayed approving Moderna's
vaccine for use in 12 to 17 year olds as it investigated
the risk of heart inflammation in young men. .
Last fall, the FDA delayed approving Moderna's
vaccine for use in 12 to 17 year olds as it investigated
the risk of heart inflammation in young men.
On January 31, Moderna announced that its
COVID-19 vaccine has been granted full approval
by United States health regulators. .
On January 31, Moderna announced that its
COVID-19 vaccine has been granted full approval
by United States health regulators. .
The Associated Press reports that since its
emergency authorization over a year ago, the vaccine
has already been given to tens of millions of Americans. .
The Associated Press reports that since its
emergency authorization over a year ago, the vaccine
has already been given to tens of millions of Americans. .
In August of 2021, the FDA granted
full approval to Pfizer's vaccine.
The Associated Press reports that over
211 million Americans are fully vaccinated -
about 63% of the population. .
The Associated Press reports that over
211 million Americans are fully vaccinated -
about 63% of the population. .
Approximately 86 million people have
received at least one dose of a booster. .
According to the AP, vaccinations peaked at over
3 million doses were distributed per day last spring.
Now, daily doses average less than 750,000. .
The AP reports that the vaccine's initial
emergency approval was based on a study
that tracked 44,000 people for two months.
Moderna then continued that study
to complete longer six-month-long studies
normally required for full approval. .
The FDA reportedly monitored for serious side effects that have proven to be extremely rare. .
The FDA reportedly monitored for serious side effects that have proven to be extremely rare. .
Last fall, the FDA delayed approving Moderna's
vaccine for use in 12 to 17 year olds as it investigated
the risk of heart inflammation in young men. .
Last fall, the FDA delayed approving Moderna's
vaccine for use in 12 to 17 year olds as it investigated
the risk of heart inflammation in young men.